Adam Roth

Adam Roth is the VP and Head of Business Operations at Galvani Bioelectronics. Adam was previously the Head of Business Development for Bioelectronics R&D at GSK, where they were responsible for partnership and licensing for the program to develop bioelectric therapies. Prior to that, Adam worked as a management consultant at McKinsey & Company, serving pharmaceutical and healthcare clients. Adam also has experience as a research and teaching assistant at The University of Texas at Austin, where they conducted molecular biology research and taught multiple courses. Adam began their career as a senior financial analyst at Intel, where they were a capital analyst in the Technology Manufacturing Group (TMG).

Adam Roth has a PhD in Cellular and Molecular Biology from The University of Texas at Austin, an MBA in Finance and Entrepreneurship from the University of Colorado Boulder - Leeds School of Business, and a BS in Engineering Science and Mechanics from the University of Tennessee, Knoxville.

Adam Roth works with Firat Yazicioglu - VP, Head of Translation & Engineering, René Van Der Merwe - Chief Medical Officer & Head of Clinical Development, and Kathy Jo Fahey - VP, Head of Regulated Development. Adam Roth reports to Kristoffer Famm, President, Galvani Bioelectronics.